Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Planned sale Chief Executive Officer sold 25,000 shares at an average $64.88 ($1,621,894)
  6. 4 Shares withheld for taxes Chief Medical Officer gave up 2,527 shares (to pay taxes)
  7. 4 Planned sale Chief Executive Officer sold 25,000 shares at an average $50.67 ($1,266,638)
  8. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $44.46 ($1,111,504)
  9. 4 Derivatives Options or other derivatives
  10. 4 Shares withheld for taxes Chief Executive Officer gave up 9,444 shares (to pay taxes)
  11. 4 Shares withheld for taxes General Counsel and Secretary gave up 2,305 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $48.25 ($1,206,243)
  15. 4 Shares withheld for taxes Chief Financial Officer gave up 1,392 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Executive Officer gave up 6,373 shares (to pay taxes)
  17. 4 Shares withheld for taxes General Counsel and Secretary gave up 1,950 shares (to pay taxes)
  18. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $51.47 ($1,286,798)
  19. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $40.93 ($1,023,290)
  20. 4 Option exercise Chief Executive Officer acquired 58,233 shares (option exercise)

Page 8 of 26 · 502 filings